Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.

Neurobiology of aging - 1 Apr 2022

Oltra-Cucarella Javier, Sánchez-SanSegundo Miriam, Ferrer-Cascales Rosario

Abstract excerpt

After the paper Cognition or genetics. Predicting progression to Alzheimer's disease with practice effects, APOE genotype and brain metabolism [Neurobiol Aging, 2018; 71:234-240] was published, we identified a coding error of one of the variables analyzed. To correct, update and expand the previous work, we compared simple and complex regression-based Reliable Change Index (RCIRB) to analyze the risk of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Genotype

Share to Neuropsychological Tests

Source

Identifiers

PMID: 35121484
DOI: 10.1016/j.neurobiolaging.2021.12.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.PMID 35121484Read ↗

Cognition or genetics? Predicting Alzheimer's disease with practice effects, APOE genotype, and brain metabolism.Semantic proximity Read ↗

Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)Semantic proximity Read ↗

Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.Semantic proximity Read ↗

Alzheimer’s environmental and genetic risk scores are differentially associated with ‘g’ and δSemantic proximity Read ↗

ANU-ADRI and not Genetic Risk score predicts MCI in a cohort of older adults followed for 12 yearsSemantic proximity Read ↗

Predicting 24-Month MCI-to-Alzheimer’s Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic TestingSemantic proximity Read ↗

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Semantic proximity Read ↗

Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE.Semantic proximity Read ↗

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s DiseaseSemantic proximity Read ↗

Predicting amyloid beta accumulation in cognitively unimpaired older adults: Cognitive assessments provide no additional utility beyond demographic and genetic factorsSemantic proximity Read ↗

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's diseaseSemantic proximity Read ↗

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.